First in Series of Reports on Public Policy and Regulatory Issues More and more companies face multifaceted and growing risks across all government, with distinct and emerging risks from Congress and in specific state capitals.”
— HBS CEO Andy Blunt WASHINGTON, DC, USA, August 22, 2024 /EINPresswire.com/ -- Any talk of private equity investment in healthcare is certain to stir a spirited discussion as firms have purchased over 6,000 physician practices, 460 hospitals, and five-percent of nursing homes nationwide over the past decade. The wide held view is that PE investments save shuttering healthcare facilities, expand healthcare access, and power medical advancements, however, some insist that PE-controlled facilities charge more, cost more to operate, and compromise the quality of care practiced.
In the first of a new series of public policy and regulatory reports, the HBS team assesses current risks from Congress and state legislatures to private equity investments in healthcare. The HBS REPORT Private Equity Investment in Healthcare outlines obstacles impacting private equity and provides a proactive blueprint to safeguard innovative investments in healthcare.
HBS CEO Andy Blunt noted at the release of the report, “More and more companies face multifaceted and growing risks across all government, with distinct and emerging risks from Congress and in specific state capitals. Our new series, HBS Report, will identify and examine the potential legislative and regulatory obstacles and opportunities through the lens of our team of professional lobbyists and public affairs advisors nationwide.”
ABOUT HBS
Husch Blackwell Strategies was established in 2018 with the merger of three government affairs practices of Husch Blackwell LLP, Statehouse Strategies LLC, and Cloakroom Advisors LLC, to form a multi-jurisdiction state and federal legislative government affairs firm. HBS Chief Executive Officer Andy Blunt and HBS Chief Operating Officer Gregg Hartley are co-founders of the firm. Today, HBS moves the needle of public opinion and guides decisions of public officials through its integrated services of state and federal lobbying, executive-level strategic counsel, and public affairs. With one of the largest networks of state lobbyists in the country, HBS has twelve offices nationwide – in Arizona, Arkansas, Colorado, Kansas, Maryland, Missouri, Nebraska, Oklahoma, Texas, Wisconsin, a federal practice group that ranks as one of Washington’s top performing lobbying firms, and the HBS Public Affairs group based in St. Louis. U.S. Senator Roy Blunt chairs the firm’s Leadership Strategies Advisory Services group in Washington – a specialized executive team that provides a comprehensive whole-of-government advisory service that is tailored to the needs of a specific organization.
Tom AlexanderHusch Blackwell Strategies+1 202-262-4284email us hereVisit us on social media:XLinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
You just read:
News Provided By
August 22, 2024, 19:12 GMT
EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above. Originally published at https://www.einpresswire.com/article/737528825/husch-blackwell-strategies-report-examines-private-equity-investment-in-healthcare-and-its-government-risk
